Daily PCSK9 Pill Reduces Cholesterol When Statins Aren’t Cutting It

(MedPage Today) — NEW ORLEANS — The investigational oral PCSK9 inhibitor enlicitide reduced low-density lipoprotein (LDL) cholesterol in patients with or at high risk for atherosclerotic cardiovascular disease, the phase III CORALreef Lipids…